Skip to content

VNDA - Vanda Pharmaceuticals Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchV

Vanda Pharmaceuticals Inc

VNDA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

V

VNDAVanda Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $9.94
52-wk low: $4.27
Prev close: $7.25
Mkt cap: $336.8M
Fwd P/E: 103.1x
Beta: 0.64

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$141.0M

AQ
AQR
Q2 2026 13F
$21.4M
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Jul 30, 2026

Earnings came in 103.9% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -127.4%
Forward P/E: 103.09
Market cap: $337M

Valuation

P/S1.56
P/B1.49

Quality

Operating margin-126.3%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: VNDA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $336.78M
Beta: 0.64

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

1.6x

P/B

1.5x

Profit margin

-127.4%

Op margin

-126.3%

ROE

-77.8%

$21.1M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$9.8M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for VNDA

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$1.04-103.9%

-$0.51 expected

Next report

What the street expects next

ROE

-77.8%

ROA-22.4%

Growth

Beta0.64